This is a clinical research study designed to measure changes in inflammation and the oral microbiome during a phase of good oral hygiene and the absence of oral hygiene. The goal of the study is to investigate the interplay between local oral inflammation, microbiota and systemic immune responses.
Males and females, between 18-65 years of age;
Availability for the duration of the study;
ASA 1 Good general health (absence of any self-reported systemic disease or condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve/hip replacements, etc);
Willingness to provide information related to their medical history;
Subjects with more that 2 sites with pocket depth of > 4 mm and those presenting purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone;
Oral pathology or a history of allergy to testing products;
Subject using anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study; to be defined by the dental examiner;
Subject participating in any other clinical study;
Parallel
Stannous Fluoride Toothpaste (SnF)
Drugstannous fluoride toothpaste
Gingival Bleeding Index described by Ainamo & Bay, 1976
Gingival Bleeding Index (Ainamo \& Bay, 1976) The six surfaces of teeth will be scored and recorded for absence or presence of bleeding after gentle probing.
Click on the lead sponsor to view all of their trials.
Colgate Palmolive
Lead sponsor
The University of Texas Health Science Center, Houston
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
